Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T70851 | Target Info | |||
| Target Name | Extracellular signal-regulated kinase 5 (ERK5) | ||||
| Synonyms | PRKM7; Mitogen-activated protein kinase 7; MAPK 7; MAP kinase 7; ERK-5; Big MAP kinase 1; BMK1; BMK-1 | ||||
| Target Type | Patented-recorded Target | ||||
| Gene Name | MAPK7 | ||||
| Biochemical Class | Kinase | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | |||||
| Patent ID | WO2015129927 | ||||
| Title | Heterocyclic Compounds. | ||||
| Abstract | Provided herein are compounds of formula I and compositions containing the compounds. The compounds and compositions are useful in the methods of inhibiting the action of ERK5, a BET family protein or both. In certain embodiments, the compounds and compositions are useful in the prevention, amelioration or treatment of a ERK5 -mediated disease, a BET protein-mediated disease or both. | ||||
| Applicant(s) | Kyorin Pharmaceutical Co., Ltd | ||||
| Representative Drug(s) | D0L7SK | Drug Info | N.A. | Click to Show More | [1] |
| 2 | D0SB3H | Drug Info | N.A. | [1] | |
| 3 | D0VB3P | Drug Info | N.A. | [1] | |
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.